No Detail Found!

Safety Status of Interferon-free All-oral Direct-acting Antiviral Agents (DAAs) to treat HCV patients in Tertiary Care Hospital of Faisalabad-Pakistan

Author(s)
Naveed Munir Department of Biomedical Lab Sciences, School of Health Sciences, University of Management and Technology,Lahore-,Pakistan
Hassan Akhtar Bajwa College of Allied Health Professional, Government College University, Faisalabad-Pakistan; Government Covid-19 BSL 3 Lab Wazirabad, Wazirabad-Punjab, Pakistan.
Muhammad Mohsin Aftab Institute of Public Health,Lahore-,Pakistan
Amna Bibi College of Allied Health Professional, Government College University,Faisalabad-,Pakistan
Zahed Mahmood Department of Biochemistry, Government College University,Faisalabad-,Pakistan
Muhammad Shoukat Government Covid-19 BSL 3 Lab Wazirabad,Wazirabad-Punjab,Pakistan
Muhammad Zahid Mustafa Center for Advanced Studies in Vaccinology & Biotechnology (CASVAB), University of Balochistan,Quetta,Pakistan
Shahzada Khurram Syed Department of Clinical Services, University of Management and Technology,Lahore-,Pakistan
Abstract
Objective: Current research work was planned to investigate the medication-related side effects and cytotoxic and bone marrow suppressive effects of DAAs to provide evidencebased findings to convince the local population of HCV infection treatment. Material and Methods: Present research investigated the appearance of medicationrelated side effects both in males (n=200) and females (n=200) by conducting in-depth interviews with hepatitis C patients and collecting blood samples for measuring selected haemato-biochemical parameters at DHQ Hospital, Faisalabad and Samnabad General Hospital, Faisalabad-Pakistan. Further, grouping was done based on age (below 40 years and above 40 years of old) and regime combination as double regime (SOF + Daclatasvir) and triple regime (SOF + Ribavirin + Daclatasvir). Results: It was reported that headache, fever, body aches, joint pain, heartburn, tension, aggressive behaviour, weakness and abdominal pain are among the general side effects that appeared in HCV patients on oral medications. However, the results explored that patients taking oral medication did not have vomiting, insomnia, nausea, the feeling of chill, blurred vision and tiredness-like side effects, which might imbalance the socioeconomic life of an individual. Further, cytotoxic and bone marrow suppressive effects are non-significant (p>0.05) evaluated by selected blood tests, including ALT, Haemoglobin, Neutrophils percentage, Total leucocytes count, and platelets count in comparison with a control group. Conclusion: It could be concluded that all oral direct acting antiviral therapy is safe and effective compared to previously used therapies. Moreover, physical factors reported in patients could be minimized by improving the socioeconomic status of the local population in Pakistan.
Publication Details
Page(s) 93-100
Published Journal: National Journal of Medical and Health Sciences, Volume: 4, Issue: 2, Year: 2022

Request the full text from PASTIC

Keywords
Hepatitis C treatment, direct-acting antivirals agents, interferon-free, safety profile
0

Citations

0

Downloads

45

Views